A study to evaluate the safety and efficacy of ombitasvir/ABT-450/ritonavir with sofosbuvir with or without ribavirin in adults with Chronic Hepatitis C Virus infection

Update Il y a 4 ans
Reference: EUCTR2014-003147-35

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Percentage of subjects with sustained virologic response 12 weeks post-treatment.


Inclusion criteria

  • Chronic Hepatitis C Virus (HCV) Infection

Links